James A. Tumlin

13.9k total citations
122 papers, 7.0k citations indexed

About

James A. Tumlin is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, James A. Tumlin has authored 122 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Nephrology, 22 papers in Pulmonary and Respiratory Medicine and 20 papers in Hematology. Recurrent topics in James A. Tumlin's work include Acute Kidney Injury Research (37 papers), Renal Diseases and Glomerulopathies (32 papers) and Chronic Kidney Disease and Diabetes (23 papers). James A. Tumlin is often cited by papers focused on Acute Kidney Injury Research (37 papers), Renal Diseases and Glomerulopathies (32 papers) and Chronic Kidney Disease and Diabetes (23 papers). James A. Tumlin collaborates with scholars based in United States, United Kingdom and Italy. James A. Tumlin's co-authors include Peter A. McCullough, Norbert Lameire, Fulvio Stacul, Andy Adam, Christoph R. Becker, Charles J. Davidson, Alice M. Mitchell, Alan E. Jones, Lakhmir S. Chawla and Jeffrey A. Kline and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Clinical Investigation.

In The Last Decade

James A. Tumlin

114 papers receiving 6.8k citations

Peers

Countries citing papers authored by James A. Tumlin

Since Specialization

Citations

This map shows the geographic impact of James A. Tumlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Tumlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Tumlin more than expected).

Fields of papers citing papers by James A. Tumlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Tumlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Tumlin. The network helps show where James A. Tumlin may publish in the future.

Co-authorship network of co-authors of James A. Tumlin

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Tumlin. A scholar is included among the top collaborators of James A. Tumlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Tumlin. James A. Tumlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting the Type I Interferon Pathway in Glomerular Kidney Disease: Rationale and Therapeutic Opportunities 2024 ·Kidney International Reports ·James A. Tumlin, Brad H. Rovin, Hans‐Joachim Anders, Eduardo Mysler, David Jayne, (unknown), Catharina Lindholm, Gudrun Weiss, Alessandro Sorrentino, Kevin Woollard, Nicola Ferrari	2
2	Vadadustat Three Times Weekly in Patients With Anemia Due to Dialysis-Dependent CKD 2024 ·American Journal of Kidney Diseases ·Hakan R. Toka, Marializa Bernardo, Steven K. Burke, (unknown), (unknown), Irfan Ullah, Zhihui Yang, Zuo‐Feng Zhang, James A. Tumlin	2
3	WCN24-762 UPDATED RESULTS FROM THE RUBY-3 STUDY OF POVETACICEPT, AN ENHANCED DUAL BAFF/APRIL ANTAGONIST, IN AUTOANTIBODY-ASSOCIATED GLOMERULONEPHRITIS 2024 ·Kidney International Reports ·James A. Tumlin, Sreedhar Mandayam, (unknown), Frank B. Cortazar, Sang-Woong Han, Hemant Kulkarni, Jonathan Barratt, Brad H. Rovin, Hong Zhang, R. H. Davies, Amanda Enstrom, (unknown), Jiahua Li, Stanford L. Peng, Harmeet Singh	1
4	Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia 2024 ·Kidney International ·David M. Charytan, Wolfgang C. Winkelmayer, Christopher B Granger, John P. Middleton, Charles A. Herzog, Glenn M. Chertow, James M. Eudicone, Jeremy Whitson, James A. Tumlin	3
5	Association of Dialysate Bicarbonate with Arrhythmia in the Monitoring in Dialysis Study 2024 ·Kidney360 ·(unknown), James A. Tumlin, Prabir Roy‐Chaudhury, Bruce A. Koplan, Alexandru Costea, Vijay Kher, Don Williamson, Candace K. McClure, David M. Charytan, Finnian R. Mc Causland	0
6	WCN23-1117 ATRASENTAN IN PATIENTS WITH PROTEINURIC GLOMERULAR DISEASES – THE AFFINITY STUDY 2023 ·Kidney International Reports ·Sung‐Hoon Kim, (unknown), (unknown), Richard Lafayette, Eugenie Pedagogos, Michelle N. Rheault, James A. Tumlin, Todd DeVries, Khushboo Sheth, Maria Emília Camargo, (unknown), (unknown), Seung Hyeok Han	0
7	Association of Bradycardia and Asystole Episodes with Dialytic Parameters: An Analysis of the Monitoring in Dialysis (MiD) Study 2022 ·Kidney360 ·(unknown), Nisha Bansal, Wolfgang C. Winkelmayer, Bruce A. Koplan, Alexandru Costea, Prabir Roy‐Chaudhury, James A. Tumlin, Vijay Kher, Don Williamson, Saurabh Pokhariyal, Candace K. McClure, David M. Charytan	4
8	Iron-Related Outcomes in Patients with Dialysis-Dependent CKD Randomized to Vadadustat vs. Darbepoetin Alfa 2021 ·Journal of the American Society of Nephrology ·Wolfgang C. Winkelmayer, Steven Fishbane, James A. Tumlin, Youssef M.K. Farag, Wei Luo, Robert A. Anders, (unknown), Dennis Vargo, Mark J. Koury	1
9	The Influence of an Elastase-Sensitive Complement C5 Variant on Lupus Nephritis and Its Flare 2021 ·Kidney International Reports ·(unknown), Huijuan Song, Haikady N. Nagaraja, J. Allen Scott, (unknown), Xiaolan Zhang, C. Yung Yu, James A. Tumlin, Brad H. Rovin, Lee A. Hebert, Daniel J. Birmingham	1
10	Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial 2020 ·American Journal of Respiratory and Critical Care Medicine ·Rinaldo Bellomo, Lui G. Forni, Laurence W. Busse, Michael T. McCurdy, Kealy R. Ham, David W. Boldt, Johanna Hästbacka, Ashish K. Khanna, Timothy E. Albertson, James A. Tumlin, (unknown), Damian Handisides, George F. Tidmarsh, Lakhmir S. Chawla, Marlies Ostermann	121
11	Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II 2018 ·Critical Care Medicine ·James A. Tumlin, Raghavan Murugan, Adam M. Deane, Marlies Ostermann, Laurence W. Busse, Kealy R. Ham, Kianoush Kashani, Harold M. Szerlip, John R. Prowle, Azra Bihorac, Kevin W. Finkel, Alexander Zarbock, Lui G. Forni, S. Lynch, (unknown), Stew Kroll, Lakhmir S. Chawla, George F. Tidmarsh, Rinaldo Bellomo	193
12	Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography 2018 ·JACC: Cardiovascular Interventions ·Roxana Mehran, Michela Faggioni, Jaya Chandrasekhar, Dominick J. Angiolillo, Barry Bertolet, Robert Jobe, (unknown), Somjot Brar, George Dangas, Wayne Batchelor, Anand Prasad, Hitinder S. Gurm, James A. Tumlin, Gregg W. Stone	34
13	Development and Standardization of a Furosemide Stress Test to Predict the Severity of Acute Kidney Injury 2013 ·Critical Care ·Lakhmir S. Chawla, Danielle Davison, Ermira Brasha-Mitchell, Jay L. Koyner, John M. Arthur, Andrew Shaw, James A. Tumlin, (unknown), Paul L. Kimmel, Michael G. Seneff	232
14	Urinary Angiotensinogen and Risk of Severe AKI 2012 ·Clinical Journal of the American Society of Nephrology ·Joseph L. Alge, Nithin Karakala, Benjamin A. Neely, Michael G. Janech, James A. Tumlin, Lakhmir S. Chawla, Andrew Shaw, John M. Arthur	59
15	Soluble urokinase receptor and focal segmental glomerulosclerosis 2012 ·Current Opinion in Nephrology & Hypertension ·Jochen Reiser, Changli Wei, James A. Tumlin	26
16	Abstract No. 152: A phase III, randomized, double-blind, placebo-controlled study of tenecteplase for improvement of hemodialysis catheter function: TROPICS 3 2010 ·Journal of Vascular and Interventional Radiology ·James A. Tumlin, (unknown), David Spiegel, (unknown), (unknown), Martha Blaney, J. Kenneth Jacobs, Barbara S. Gillespie, Susan M. Begelman	1
17	Efficacy and Safety of Renal Tubule Cell Therapy for Acute Renal Failure 2008 ·Journal of the American Society of Nephrology ·James A. Tumlin, Ravinder K. Wali, (unknown), Patrick Murray, Ashita Tolwani, Anna K. Vinnikova, Harold M. Szerlip, (unknown), (unknown), Lance D. Dworkin, Kevin W. Finkel, Michael A. Kraus, H. David Humes	143
18	High-Risk Situations and Procedures 2006 ·The American Journal of Cardiology ·Christoph R. Becker, Charles J. Davidson, Norbert Lameire, Peter A. McCullough, Fulvio Stacul, James A. Tumlin, Andy Adam	28
19	Strategies to Reduce the Risk of Contrast-Induced Nephropathy 2006 ·The American Journal of Cardiology ·Fulvio Stacul, Andy Adam, Christoph R. Becker, Charles J. Davidson, Norbert Lameire, Peter A. McCullough, James A. Tumlin	191
20	Evidence that the inhibition of Na+/K+-ATPase activity by FK506 involves calcineurin 1994 ·Kidney International ·Janice P. Lea, Jeff M. Sands, (unknown), James A. Tumlin	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact